BISACCIA EMIL has a total of 16 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and environmental technology are TARIS BIOMEDICAL INC, TARIS BIOMEDICAL LLC and LICONSA LABORATORIOS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 | |
#6 | Hungary | 1 | |
#7 | Israel | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Syringes | |
#3 | Object sterilising | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Klainer Albert S | 15 |
#2 | Bisaccia Emil | 14 |
#3 | Emil Bisaccia | 2 |
#4 | Albert S Klainer | 1 |
Publication | Filing date | Title |
---|---|---|
AU3416593A | Treatment of lymes disease and associated debilitating conditions | |
CA2117330A1 | The use of psoralen compounds to inhibit restenosis following angioplasty | |
US5284869A | Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty | |
US5219882A | Treatment methods for lymes disease and associated debilitating conditions | |
ZA9000171B | Treatment methods and vaccines for stimulating an immune response | |
IL92996A | Photoactive compounds as medicaments for the treatment of virus infections and method for production of vaccines |